SAMSUNG PHARMACEUTICAL.CO.,Ltd.
001360 | KO
Overview
Corporate Details
- ISIN(s):
- KR7001360007
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단4길 10 -, 화성시
- Website:
- http://www.sspharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-25 00:00 |
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 12.2 KB | ||
| 2025-08-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 63.8 KB | ||
| 2025-08-21 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 5.8 KB | ||
| 2025-08-20 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 134.9 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.1 MB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 916.3 KB | ||
| 2025-08-08 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 67.1 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 896.6 KB | ||
| 2025-03-27 00:00 |
AGM Information
정기주주총회결과 (제 71기)
|
Korean | 22.5 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 11.9 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 495.1 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 9.2 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 120.2 KB | ||
| 2025-03-12 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 83.1 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.4 KB |
Automate Your Workflow. Get a real-time feed of all SAMSUNG PHARMACEUTICAL.CO.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SAMSUNG PHARMACEUTICAL.CO.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAMSUNG PHARMACEUTICAL.CO.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
United Kingdom
AVCT
United Kingdom
AVCT
Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.
United States of America
AVDL
United States of America
AVDL
Delivers clinical lab services & develops diagnostics, CAR-T therapies, and exosome technology.
United States of America
ALBT
United States of America
ALBT
Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.
United States of America
RNA
United States of America
RNA
Develops surgical solutions, including nerve allografts, for peripheral nerve repair and regeneration.
United States of America
AXGN
United States of America
AXGN
Biopharma company developing novel therapies for central nervous system (CNS) conditions.
United States of America
AXSM
United States of America
AXSM
Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.
United States of America
AYTU
United States of America
AYTU
Developing engineered proteins and live biotherapeutics for rare skin diseases.
United States of America
AZTR
United States of America
AZTR
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Switzerland
BANB
Develops T cell immunotherapies for autoimmune and chronic infectious diseases.
United States of America
BRNS
United States of America
BRNS